ecancer

Daratumumab shows remarkable benefit in relapsed or refractory MM

Prof Meletios Dimopoulos - University Athens School of Medicine, Athens, Greece

$Daratumumab shows remarkable benefit in relapsed or refractory MM ( Prof Meletios Dimopoulos - University Athens School of Medicine, Athens, Greece )$

10 Jun 2016

Pre-leukaemic clones that survive chemo linked to higher risk of AML recurrence

Dr Klaus Metzeler - Ludwig-Maximilians-Universität, Munich, Germany

10 Jun 2016

Blinatumomab improves survival in ALL patients

Prof Max Topp - University of Würzburg, Würzburg, Germany

10 Jun 2016

Stopping tyrosine kinase inhibitors in CML

Dr Johan Richter - Lund University, Sweden

10 Jun 2016

Evaluation of ibrutinib in treatment of CLL with 17p deletion

Dr Jeffrey Jones - OSU James Cancer Hospital, Columbus, USA

10 Jun 2016

Nivolumab restores effective anti-tumour response in Hodgkin lymphoma

Dr Anas Younes - Memorial Sloan Kettering Cancer Centre, New York, USA

10 Jun 2016

An overview of MCL from EHA 2016

Professor Simon Rule and Professor Steven Le Gouill

10 Jun 2016

Adjuvant docetaxel fails after radical prostatectomy for high risk prostate cancer

Dr Goran Ahlgren - Lund University, Malmö, Sweden

6 Jun 2016

Daratumumab slows progression in refractory multiple myeloma

Prof Palumbo - University of Turin, Turin, Italy

$Daratumumab slows progression in refractory multiple myeloma ( Prof Palumbo - University of Turin, Turin, Italy )$

6 Jun 2016

Developments in haematological malignancies

Dr Stephen Nimer - University of Miami, Miami, USA

6 Jun 2016

First results of a prospective bendamustine/rituximab trial in patients with MCL

Dr Mathias Rummel - University of Giessen, Giessen, Germany

6 Jun 2016

Upfront autologous stem cell transplantation for newly diagnosed multiple myeloma

Prof Michele Cavo - Seràgnoli Institute of Hematology, Bologna, Italy

6 Jun 2016

More from ecancer